WASHINGTON — A top U.S. health official on Thursday called on lawmakers in Congress to do more to help bring down drug prices, saying that the Trump administration had “given them a lot of opportunities to step in here.”

“I think Congress can do more,” said Joe Grogan, associate director for health programs at the Office of Management and Budget. He added: “As we get to the sprint before the end of the year, there are a few things that they may take up, and we’re actively in discussions about that.”

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • This is pure stagecraft or propaganda. It is like asking the fox to guard the hen house. The only thing for sure is that Congress will continue to ensure the profits of pharma, even as Americans die. Pharma gets what it pays for.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy